Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…
84,540$
-3,13%
Echtzeit-Aktienkurs ANI Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur ANI Pharmaceuticals Inc. Aktie
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Here is how ANI Pharmaceuticals (ANIP) and Black Diamond (BDTX) have performed compared to their sector so far this year.…
Did ANI Pharmaceuticals (ANIP) Upgraded 2025 Outlook Just Shift Its Investment Narrative?
ANI Pharmaceuticals recently raised its full-year 2025 earnings guidance, now expecting net revenue of US$854 million to US$873 million, up…
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director
MIAMI, Oct. 20, 2025 (GLOBE NEWSWIRE) -- HOPE Therapeutics™, Inc. ("HOPE"), an interventional psychiatry network owned by NRx…
Ionis Pharmaceuticals Aktie: Positive Phase-3-Daten beflügeln Analystenmeinung - Upgrade!
New York (www.aktiencheck.de) - Ionis Pharmaceuticals-Aktienanalyse von Goldman Sachs:Salveen Richter von Goldman Sachs stuft die Aktie von Ionis Pharmaceuticals Inc.…
Is Clover Health Investments (CLOV) Outperforming Other Medical Stocks This Year?
Here is how Clover Health Investments, Corp. (CLOV) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far…
Ionis Pharmaceuticals Aktie: Phase-3-Erfolg bei Alexander-Krankheit beflügelt Kursziel
London (www.aktiencheck.de) - Ionis Pharmaceuticals-Aktienanalyse von Barclays:Die Analystin Gena Wang von Barclays bestätigt für die Aktie von Ionis Pharmaceuticals Inc.…
Ionis Pharmaceuticals Aktienanalyse: Tryngolza und Dawnzera starten durch - Raymond James passt Kursziel an!
Bad Marienberg (www.aktiencheck.de)???? Ionis Pharmaceuticals begeistert Analysten: Raymond James hebt Kursziel auf 75 USD - "strong buy"Ionis Pharmaceuticals Inc. (ISIN:…
Aurinia Pharmaceuticals Inc. (AUPH) Q2 2025 Earnings Call Transcript
…
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Q2 Release
ANI (ANIP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…
NRx Pharmaceuticals, Inc. (NRXP) Q1 2025 Earnings Call Transcript
…
Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?
Here is how ANI Pharmaceuticals (ANIP) and Agenus (AGEN) have performed compared to their sector so far this year.…
ANI Pharmaceuticals: A Short-Term Buying Opportunity
…
Buy 4 Low-Beta Stocks ANIP, LRN, MASS & CTGO as Tariff Woes Continue
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Stride, 908 Devices, &…
Tariff Woes? Play Safe With 4 Low-Beta Stocks: ANIP, EXE, AVA & CTGO
It is imperative to build a portfolio of low-beta stocks in a volatile market. ANI Pharmaceuticals, Expand Energy, Avista &…
Zacks.com featured highlights include HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree
HIS, ANI Pharmaceuticals, Pediatrix Medical, Fresenius Medical Care and LendingTree are part of the Zacks Screen of the Week article.…